Literature DB >> 10935334

Mitral valve plasty in systemic lupus erythematosus in the setting of antiphospholipid syndrome.

M Yoshida1, Y Sasako, J Kobayashi, K Minatoya, K Bando, S Kitamura.   

Abstract

The first case was of a 27-year-old female, who was diagnosed as having mitral valve stenosis with regurgitation, systemic lupus erythematosus and antiphospholipid syndrome at her previous pregnancy. We performed mitral valve plasty, which included open mitral commissurotomy and Kay's annulo plasty. The second case was of a 53-year-old female, who was diagnosed as old myocardial infarction, mitral regurgitation, systemic lupus erythematosus and antiphospholipid syndrome. She underwent mitral valve plasty and coronary artery bypass grafting. Both cases were treated by administration of methylpredonisolone and heparin perioperatively to avoid thrombosis and aggravation of systemic lupus erythematosus. Both patients showed good postoperative outcome without complications. We consider that it is important to perform the plasty as far as possible, and to administer effective anticoagulation treatment to prevent complications for patients in the setting of systemic lupus erythematosus and antiphospholipid syndrome.

Entities:  

Mesh:

Year:  2000        PMID: 10935334     DOI: 10.1007/bf03218164

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  6 in total

1.  Recognition and management of patients with antiphospholipid antibody syndrome undergoing cardiac surgery.

Authors:  F Sheikh; A Lechowicz; R Setlur; A Rauch; H Dunn
Journal:  J Cardiothorac Vasc Anesth       Date:  1997-10       Impact factor: 2.628

Review 2.  Cerebral and valve lesions in SLE: association with antiphospholipid antibodies.

Authors:  R A Asherson; W F Lubbe
Journal:  J Rheumatol       Date:  1988-04       Impact factor: 4.666

3.  [Successful surgical treatment of mitral regurgitation associated with anti-phospholipid syndrome and systemic lupus erythematosus].

Authors:  S Noji; N Kitamura; T Miki; S Kimura; K Shunto; A Yamaguchi
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1995-08

4.  Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings.

Authors:  R García-Torres; M C Amigo; A de la Rosa; A Morón; P A Reyes
Journal:  Lupus       Date:  1996-02       Impact factor: 2.911

5.  Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus.

Authors:  P M Ford; S E Ford; D P Lillicrap
Journal:  J Rheumatol       Date:  1988-04       Impact factor: 4.666

6.  Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  E K Chartash; D M Lans; S A Paget; T Qamar; M D Lockshin
Journal:  Am J Med       Date:  1989-04       Impact factor: 4.965

  6 in total
  2 in total

1.  Mitral insufficiency associated with primary antiphospholipid syndrome and chronic renal failure.

Authors:  Y Kato; F Isobe; Y Sasaki; K Kodera; H Kumano; K Nagamachi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-03

Review 2.  The Heart and APS.

Authors:  Mary-Carmen Amigo
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.